| 【Company Research】Cutia Therapeutics (2487 HK) – Well-positioned to capture broader dermatology market potential |
| 【Sector Research】China Technology – Implications of TSMC 2Q23: slower 3Q and China recovery; AI is too small to move the needle |
| 【Company Research】Nayuki (2150 HK) – Franchising can be the new recipe for success |
| 【Company Research】Kuaishou (1024 HK) – Share gain to continue with earnings upside |
| 【Company Research】Sunny Optical (2382 HK) – 1H23 profit warning worse than feared; Maintain Hold |
| 【Company Research】Xtep (1368 HK) – A high-quality 2Q23 and guidance unchanged |
| 【Company Research】BeiGene (BGNE US) – R&D Day takeaways: solidifying leadership in haematology with three synergistic BIC molecules |
| 【Company Research】Yili Industrial (600887 CH) – Full-year guidance unchanged |
| 【Company Research】Anta Sports (2020 HK) – A slight beat in 2Q23 but outlook is still fragile |
| 【Company Research】Q-Tech (1478 HK) – 1H23 profit warning; Maintain BUY on 2H gradual recovery |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
